Noninfectious mixed cryoglobulinaemic glomerulonephritis and monoclonal gammopathy of undetermined significance: a coincidental association?

BMC Nephrol. 2020 Jul 23;21(1):293. doi: 10.1186/s12882-020-01941-3.

Abstract

Background: Cryoglobulins are cold-precipitable immunoglobulins that may cause systemic vasculitis including cryoglobulinaemic glomerulonephritis (CGN). Type 1 cryoglobulins consist of isolated monoclonal immunoglobulin (mIg), whereas mixed cryoglobulins are typically immune complexes comprising either monoclonal (type 2) or polyclonal (type 3) Ig with rheumatoid activity against polyclonal IgG. Only CGN related to type 1 cryoglobulins has been clearly associated with monoclonal gammopathy of undetermined significance (MGUS) using the conventional serum-, urine- or tissue-based methods of paraprotein detection.

Case presentation: We present four patients with noninfectious mixed (type 2 or 3) CGN and MGUS. Two patients had type 2 cryoglobulinaemia, one had type 3 cryoglobulinaemia, and one lacked definitive typing of the serum cryoprecipitate. The serum monoclonal band was IgM-κ in all four cases. Treatments included corticosteroids, cyclophosphamide, plasma exchange, and rituximab. At median 3.5 years' follow-up, no patient had developed a haematological malignancy or advanced chronic kidney disease. Other potential causes of mixed cryoglobulinaemia were also present in our cohort, notably primary Sjögren's syndrome in three cases.

Conclusion: Our study raises questions regarding the current designation of type 2 CGN as a monoclonal gammopathy of renal significance, and the role of clonally directed therapies for noninfectious mixed CGN outside the setting of haematological malignancy.

Keywords: Cryoglobulinaemia; Glomerulonephritis; Monoclonal gammopathy of renal significance.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cryoglobulinemia / blood
  • Cryoglobulinemia / complications*
  • Cryoglobulinemia / therapy
  • Cryoglobulins*
  • Cyclophosphamide / therapeutic use
  • Female
  • Glomerulonephritis / complications*
  • Glomerulonephritis / therapy
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulin M / blood*
  • Immunoglobulin kappa-Chains / blood*
  • Immunologic Factors / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance / blood
  • Monoclonal Gammopathy of Undetermined Significance / complications*
  • Monoclonal Gammopathy of Undetermined Significance / therapy
  • Plasma Exchange
  • Rituximab / therapeutic use
  • Sjogren's Syndrome / complications*

Substances

  • Cryoglobulins
  • Glucocorticoids
  • Immunoglobulin M
  • Immunoglobulin kappa-Chains
  • Immunologic Factors
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide